1. Home
  2. JBLU vs MNMD Comparison

JBLU vs MNMD Comparison

Compare JBLU & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$5.06

Market Cap

1.5B

ML Signal

HOLD

Logo Mind Medicine (MindMed) Inc.

MNMD

Mind Medicine (MindMed) Inc.

HOLD

Current Price

$13.50

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
MNMD
Founded
1998
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JBLU
MNMD
Price
$5.06
$13.50
Analyst Decision
Sell
Strong Buy
Analyst Count
9
9
Target Price
$4.76
$30.33
AVG Volume (30 Days)
16.9M
2.1M
Earning Date
01-27-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,095,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$4.70
52 Week High
$8.31
$14.81

Technical Indicators

Market Signals
Indicator
JBLU
MNMD
Relative Strength Index (RSI) 63.67 56.37
Support Level $4.51 $12.85
Resistance Level $4.70 $14.81
Average True Range (ATR) 0.19 0.76
MACD 0.00 0.03
Stochastic Oscillator 86.43 49.82

Price Performance

Historical Comparison
JBLU
MNMD

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: